<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0" xmlns:cc="http://cyber.law.harvard.edu/rss/creativeCommonsRssModule.html">
    <channel>
        <title><![CDATA[Stories by Andrea Mantovani on Medium]]></title>
        <description><![CDATA[Stories by Andrea Mantovani on Medium]]></description>
        <link>https://medium.com/@andreamantovani?source=rss-412a4189a643------2</link>
        <image>
            <url>https://cdn-images-1.medium.com/fit/c/150/150/1*JEbwejKeQB1fik5XEcQ0gw.jpeg</url>
            <title>Stories by Andrea Mantovani on Medium</title>
            <link>https://medium.com/@andreamantovani?source=rss-412a4189a643------2</link>
        </image>
        <generator>Medium</generator>
        <lastBuildDate>Tue, 17 Nov 2026 04:20:37 GMT</lastBuildDate>
        <atom:link href="https://medium.com/@andreamantovani/feed" rel="self" type="application/rss+xml"/>
        <webMaster><![CDATA[yourfriends@medium.com]]></webMaster>
        <atom:link href="http://medium.superfeedr.com/" rel="hub"/>
        <item>
            <title><![CDATA[THE EU HTA REGULATION AND JOINT CLINICAL ASSESSMENT: Turning Regulatory Promise into Market Access…]]></title>
            <description><![CDATA[<div class="medium-feed-item"><p class="medium-feed-image"><a href="https://medium.com/@andreamantovani/the-eu-hta-regulation-and-joint-clinical-assessment-turning-regulatory-promise-into-market-access-7e7a6a40a3c0?source=rss-412a4189a643------2"><img src="https://cdn-images-1.medium.com/max/928/0*lTuOMw3UMD951bJJ" width="928"></a></p><p class="medium-feed-snippet">Executive Summary</p><p class="medium-feed-link"><a href="https://medium.com/@andreamantovani/the-eu-hta-regulation-and-joint-clinical-assessment-turning-regulatory-promise-into-market-access-7e7a6a40a3c0?source=rss-412a4189a643------2">Continue reading on Medium »</a></p></div>]]></description>
            <link>https://medium.com/@andreamantovani/the-eu-hta-regulation-and-joint-clinical-assessment-turning-regulatory-promise-into-market-access-7e7a6a40a3c0?source=rss-412a4189a643------2</link>
            <guid isPermaLink="false">https://medium.com/p/7e7a6a40a3c0</guid>
            <category><![CDATA[eu-hta]]></category>
            <category><![CDATA[jca]]></category>
            <category><![CDATA[market-access-strategy]]></category>
            <category><![CDATA[heor]]></category>
            <category><![CDATA[pricing-strategy]]></category>
            <dc:creator><![CDATA[Andrea Mantovani]]></dc:creator>
            <pubDate>Fri, 20 Mar 2026 11:32:52 GMT</pubDate>
            <atom:updated>2026-03-20T11:32:52.249Z</atom:updated>
        </item>
        <item>
            <title><![CDATA[How MFN Pricing Is Reshaping Pharmaceutical Strategy: From M&A Deal Structures to Global Launch…]]></title>
            <description><![CDATA[<div class="medium-feed-item"><p class="medium-feed-image"><a href="https://medium.com/@andreamantovani/how-mfn-pricing-is-reshaping-pharmaceutical-strategy-from-m-a-deal-structures-to-global-launch-e7ef35bccede?source=rss-412a4189a643------2"><img src="https://cdn-images-1.medium.com/max/1132/0*ryJLPPexODRCeS0m" width="1132"></a></p><p class="medium-feed-snippet">The pharmaceutical industry stands at an inflection point. Most Favored Nation (MFN) pricing mechanisms introduced through the Trump&#x2026;</p><p class="medium-feed-link"><a href="https://medium.com/@andreamantovani/how-mfn-pricing-is-reshaping-pharmaceutical-strategy-from-m-a-deal-structures-to-global-launch-e7ef35bccede?source=rss-412a4189a643------2">Continue reading on Medium »</a></p></div>]]></description>
            <link>https://medium.com/@andreamantovani/how-mfn-pricing-is-reshaping-pharmaceutical-strategy-from-m-a-deal-structures-to-global-launch-e7ef35bccede?source=rss-412a4189a643------2</link>
            <guid isPermaLink="false">https://medium.com/p/e7ef35bccede</guid>
            <category><![CDATA[life-sciences]]></category>
            <category><![CDATA[pricing-strategy]]></category>
            <category><![CDATA[nmf]]></category>
            <category><![CDATA[oncology]]></category>
            <category><![CDATA[rare-disease]]></category>
            <dc:creator><![CDATA[Andrea Mantovani]]></dc:creator>
            <pubDate>Fri, 20 Mar 2026 11:21:53 GMT</pubDate>
            <atom:updated>2026-03-20T11:21:53.860Z</atom:updated>
        </item>
        <item>
            <title><![CDATA[Access and reimbursement pathways for digital health solutions and in vitro diagnostic devices…]]></title>
            <description><![CDATA[<div class="medium-feed-item"><p class="medium-feed-image"><a href="https://medium.com/@andreamantovani/access-and-reimbursement-pathways-for-digital-health-solutions-and-in-vitro-diagnostic-devices-5ebd56770d89?source=rss-412a4189a643------2"><img src="https://cdn-images-1.medium.com/max/600/0*ncsB1XZpA-JePHxI.jpg" width="600"></a></p><p class="medium-feed-snippet">Andrea Mantovani1,2,&#x2020;,</p><p class="medium-feed-link"><a href="https://medium.com/@andreamantovani/access-and-reimbursement-pathways-for-digital-health-solutions-and-in-vitro-diagnostic-devices-5ebd56770d89?source=rss-412a4189a643------2">Continue reading on Medium »</a></p></div>]]></description>
            <link>https://medium.com/@andreamantovani/access-and-reimbursement-pathways-for-digital-health-solutions-and-in-vitro-diagnostic-devices-5ebd56770d89?source=rss-412a4189a643------2</link>
            <guid isPermaLink="false">https://medium.com/p/5ebd56770d89</guid>
            <category><![CDATA[reimbursement]]></category>
            <category><![CDATA[market-access-strategy]]></category>
            <category><![CDATA[in-vitro-diagnostics]]></category>
            <category><![CDATA[healthcare]]></category>
            <category><![CDATA[digital-therapeutics]]></category>
            <dc:creator><![CDATA[Andrea Mantovani]]></dc:creator>
            <pubDate>Wed, 19 Jul 2023 15:04:16 GMT</pubDate>
            <atom:updated>2023-07-19T15:04:16.052Z</atom:updated>
        </item>
        <item>
            <title><![CDATA[The 7 Habits of Highly Effective People]]></title>
            <description><![CDATA[<div class="medium-feed-item"><p class="medium-feed-image"><a href="https://medium.com/@andreamantovani/the-7-habits-of-highly-effective-people-63d86cd9cab7?source=rss-412a4189a643------2"><img src="https://cdn-images-1.medium.com/max/1021/0*8YnY6L9GYW0OuvQa" width="1021"></a></p><p class="medium-feed-snippet">Stephen R. Covey published this book back in the year 1989 as a self-improvement book. It is entirely based on the idea that what we see &amp;&#x2026;</p><p class="medium-feed-link"><a href="https://medium.com/@andreamantovani/the-7-habits-of-highly-effective-people-63d86cd9cab7?source=rss-412a4189a643------2">Continue reading on Medium »</a></p></div>]]></description>
            <link>https://medium.com/@andreamantovani/the-7-habits-of-highly-effective-people-63d86cd9cab7?source=rss-412a4189a643------2</link>
            <guid isPermaLink="false">https://medium.com/p/63d86cd9cab7</guid>
            <category><![CDATA[self-awareness]]></category>
            <category><![CDATA[leadership]]></category>
            <category><![CDATA[life-hacking]]></category>
            <category><![CDATA[self-improvement]]></category>
            <category><![CDATA[freedom]]></category>
            <dc:creator><![CDATA[Andrea Mantovani]]></dc:creator>
            <pubDate>Tue, 15 Nov 2022 19:56:22 GMT</pubDate>
            <atom:updated>2022-11-15T19:56:22.146Z</atom:updated>
        </item>
        <item>
            <title><![CDATA[REFLECTIONS ON THE “MADE IN CHINA” PLAN 2025]]></title>
            <description><![CDATA[<div class="medium-feed-item"><p class="medium-feed-image"><a href="https://medium.com/@andreamantovani/reflections-on-the-made-in-china-plan-2025-cca0242d1e72?source=rss-412a4189a643------2"><img src="https://cdn-images-1.medium.com/max/826/0*PV7J0JJ4kderg34H.jpeg" width="826"></a></p><p class="medium-feed-snippet">Few years ago, China launched an ambitious plan to become one of the leading global superpowers in technologies by 2049. The leader of the&#x2026;</p><p class="medium-feed-link"><a href="https://medium.com/@andreamantovani/reflections-on-the-made-in-china-plan-2025-cca0242d1e72?source=rss-412a4189a643------2">Continue reading on Medium »</a></p></div>]]></description>
            <link>https://medium.com/@andreamantovani/reflections-on-the-made-in-china-plan-2025-cca0242d1e72?source=rss-412a4189a643------2</link>
            <guid isPermaLink="false">https://medium.com/p/cca0242d1e72</guid>
            <category><![CDATA[innovation]]></category>
            <category><![CDATA[china]]></category>
            <category><![CDATA[heatlhcare]]></category>
            <category><![CDATA[competition]]></category>
            <category><![CDATA[europe]]></category>
            <dc:creator><![CDATA[Andrea Mantovani]]></dc:creator>
            <pubDate>Thu, 31 Mar 2022 08:31:15 GMT</pubDate>
            <atom:updated>2022-03-31T08:31:15.868Z</atom:updated>
        </item>
        <item>
            <title><![CDATA[What’s next for Orphan Drugs and ATMPs?]]></title>
            <description><![CDATA[<div class="medium-feed-item"><p class="medium-feed-image"><a href="https://medium.com/@andreamantovani/whats-next-for-orphan-drugs-and-atmps-9a9b071d8b9?source=rss-412a4189a643------2"><img src="https://cdn-images-1.medium.com/max/850/1*HoSQRmPTG8Z0Gy_83YbRBw.jpeg" width="850"></a></p><p class="medium-feed-snippet">More recently I had the opportunity to attend the World Orphan Drug Congress in Barcelona and I wanted to share my take aways and the&#x2026;</p><p class="medium-feed-link"><a href="https://medium.com/@andreamantovani/whats-next-for-orphan-drugs-and-atmps-9a9b071d8b9?source=rss-412a4189a643------2">Continue reading on Medium »</a></p></div>]]></description>
            <link>https://medium.com/@andreamantovani/whats-next-for-orphan-drugs-and-atmps-9a9b071d8b9?source=rss-412a4189a643------2</link>
            <guid isPermaLink="false">https://medium.com/p/9a9b071d8b9</guid>
            <category><![CDATA[drugs]]></category>
            <category><![CDATA[orphan-drug]]></category>
            <category><![CDATA[evaluation]]></category>
            <category><![CDATA[atmp]]></category>
            <category><![CDATA[rare-disease]]></category>
            <dc:creator><![CDATA[Andrea Mantovani]]></dc:creator>
            <pubDate>Tue, 28 Apr 2020 17:10:53 GMT</pubDate>
            <atom:updated>2020-04-28T17:10:53.046Z</atom:updated>
        </item>
        <item>
            <title><![CDATA[Known knowns, known unknowns, unknown unknowns & Leadership]]></title>
            <description><![CDATA[<div class="medium-feed-item"><p class="medium-feed-image"><a href="https://medium.com/@andreamantovani/known-knowns-known-unknowns-unknown-unknowns-leadership-367f346b0953?source=rss-412a4189a643------2"><img src="https://cdn-images-1.medium.com/max/716/0*jgXJJ5bC5bnSupZl" width="716"></a></p><p class="medium-feed-snippet">&#x201C;&#x2026;there are known knowns; there are things we know we know. We also know there are known unknowns&#x2026;</p><p class="medium-feed-link"><a href="https://medium.com/@andreamantovani/known-knowns-known-unknowns-unknown-unknowns-leadership-367f346b0953?source=rss-412a4189a643------2">Continue reading on Medium »</a></p></div>]]></description>
            <link>https://medium.com/@andreamantovani/known-knowns-known-unknowns-unknown-unknowns-leadership-367f346b0953?source=rss-412a4189a643------2</link>
            <guid isPermaLink="false">https://medium.com/p/367f346b0953</guid>
            <category><![CDATA[leadership]]></category>
            <category><![CDATA[blindspots]]></category>
            <category><![CDATA[here-and-now]]></category>
            <category><![CDATA[executive-presence]]></category>
            <category><![CDATA[self-awareness]]></category>
            <dc:creator><![CDATA[Andrea Mantovani]]></dc:creator>
            <pubDate>Tue, 28 Apr 2020 16:55:30 GMT</pubDate>
            <atom:updated>2020-04-28T16:55:30.655Z</atom:updated>
        </item>
        <item>
            <title><![CDATA[Leading in a VUCA World]]></title>
            <description><![CDATA[<div class="medium-feed-item"><p class="medium-feed-image"><a href="https://medium.com/@andreamantovani/the-pace-of-change-in-the-business-world-today-is-greater-than-our-ability-to-cope-with-it-506d283e4bc7?source=rss-412a4189a643------2"><img src="https://cdn-images-1.medium.com/max/1000/1*MNuaqoIAOSehiErIcpKVHA.jpeg" width="1000"></a></p><p class="medium-feed-snippet">The pace of change in the business world today is greater than our ability to cope with it. In a world that is described as VUCA (Volatile,</p><p class="medium-feed-link"><a href="https://medium.com/@andreamantovani/the-pace-of-change-in-the-business-world-today-is-greater-than-our-ability-to-cope-with-it-506d283e4bc7?source=rss-412a4189a643------2">Continue reading on Medium »</a></p></div>]]></description>
            <link>https://medium.com/@andreamantovani/the-pace-of-change-in-the-business-world-today-is-greater-than-our-ability-to-cope-with-it-506d283e4bc7?source=rss-412a4189a643------2</link>
            <guid isPermaLink="false">https://medium.com/p/506d283e4bc7</guid>
            <category><![CDATA[leadership]]></category>
            <category><![CDATA[vision]]></category>
            <category><![CDATA[change]]></category>
            <category><![CDATA[future-of-work]]></category>
            <category><![CDATA[vuca]]></category>
            <dc:creator><![CDATA[Andrea Mantovani]]></dc:creator>
            <pubDate>Tue, 28 Apr 2020 16:19:28 GMT</pubDate>
            <atom:updated>2020-04-28T16:28:09.227Z</atom:updated>
        </item>
        <item>
            <title><![CDATA[How bold are you as a leader?]]></title>
            <description><![CDATA[<div class="medium-feed-item"><p class="medium-feed-image"><a href="https://medium.com/@andreamantovani/how-bold-are-you-as-a-leader-4364abd63ee4?source=rss-412a4189a643------2"><img src="https://cdn-images-1.medium.com/max/1052/0*muu0dHYFTBd62CYe" width="1052"></a></p><p class="medium-feed-snippet">How bold are you as a leader in thinking, strategy and redesign?</p><p class="medium-feed-link"><a href="https://medium.com/@andreamantovani/how-bold-are-you-as-a-leader-4364abd63ee4?source=rss-412a4189a643------2">Continue reading on Medium »</a></p></div>]]></description>
            <link>https://medium.com/@andreamantovani/how-bold-are-you-as-a-leader-4364abd63ee4?source=rss-412a4189a643------2</link>
            <guid isPermaLink="false">https://medium.com/p/4364abd63ee4</guid>
            <category><![CDATA[leadership]]></category>
            <category><![CDATA[future-of-work]]></category>
            <category><![CDATA[change]]></category>
            <category><![CDATA[strategy]]></category>
            <category><![CDATA[teamwork]]></category>
            <dc:creator><![CDATA[Andrea Mantovani]]></dc:creator>
            <pubDate>Fri, 17 Jan 2020 13:42:42 GMT</pubDate>
            <atom:updated>2020-01-17T13:42:42.573Z</atom:updated>
        </item>
        <item>
            <title><![CDATA[Value Based Pricing — The way forward after recession times?]]></title>
            <description><![CDATA[<div class="medium-feed-item"><p class="medium-feed-image"><a href="https://medium.com/@andreamantovani/value-based-pricing-the-way-forward-after-recession-times-c1c69512e570?source=rss-412a4189a643------2"><img src="https://cdn-images-1.medium.com/max/600/1*KczievcGPfgLSJ26wgAmRA.jpeg" width="600"></a></p><p class="medium-feed-snippet">Recession traditionally worsens patients health outcomes and pushes countries around the world to take action on pharmaceuticals (price&#x2026;</p><p class="medium-feed-link"><a href="https://medium.com/@andreamantovani/value-based-pricing-the-way-forward-after-recession-times-c1c69512e570?source=rss-412a4189a643------2">Continue reading on Medium »</a></p></div>]]></description>
            <link>https://medium.com/@andreamantovani/value-based-pricing-the-way-forward-after-recession-times-c1c69512e570?source=rss-412a4189a643------2</link>
            <guid isPermaLink="false">https://medium.com/p/c1c69512e570</guid>
            <category><![CDATA[healthcare]]></category>
            <dc:creator><![CDATA[Andrea Mantovani]]></dc:creator>
            <pubDate>Tue, 17 Dec 2019 16:41:29 GMT</pubDate>
            <atom:updated>2019-12-17T16:41:29.132Z</atom:updated>
        </item>
    </channel>
</rss>